Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex Long-term Follow-on in Neuropathic Pain
NCT00713323Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Oct 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in neuropathic pain, sponsored by Jazz Pharmaceuticals plc. Started Oct 2005; status: completed.
02
Drugs
cannabidiol
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00713323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713323.